MAPT and Alzheimer disease: In the present study, we conducted an extensive analysis of human APOE4- and APOE3-expressing tauopathy mouse models to investigate the impact of selectively removing APOE4 from neurons on the development of major AD pathologies, including tau pathology, gliosis, neurodegeneration, neurodysfunction and myelin deficits.